75 related articles for article (PubMed ID: 6247634)
1. Varicella immunity in adults.
Groth KE; McCullough J; Balfour HH
Minn Med; 1980 Feb; 63(2):87-9. PubMed ID: 6247634
[No Abstract] [Full Text] [Related]
2. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
3. What's new in chickenpox (varicella-zoster) infection?
Gershon AA
West J Med; 1993 Feb; 158(2):180. PubMed ID: 8382001
[No Abstract] [Full Text] [Related]
4. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immunity to varicella-zoster virus: an overview.
Arvin AM
J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
[No Abstract] [Full Text] [Related]
6. Varicella serology in institutional exposure management.
Sulkes SB; Quinn EA
Am J Ment Retard; 1988 Sep; 93(2):113-7. PubMed ID: 2844213
[TBL] [Abstract][Full Text] [Related]
7. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
[TBL] [Abstract][Full Text] [Related]
9. Abortive chickenpox.
Aksoy L; Ciftçi U; Ozsoylu S
Eur J Pediatr; 1997 Mar; 156(3):248. PubMed ID: 9083772
[No Abstract] [Full Text] [Related]
10. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
Plans P; Costa J; Espuñes J; Plasència A; Salleras L
BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
[TBL] [Abstract][Full Text] [Related]
11. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
[TBL] [Abstract][Full Text] [Related]
13. [A complicated varicella infection].
Schirm J; Manson WL; Schröder FP
Ned Tijdschr Geneeskd; 1990 Oct; 134(40):1966. PubMed ID: 2172844
[No Abstract] [Full Text] [Related]
14. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
[No Abstract] [Full Text] [Related]
15. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir prophylaxis of varicella after household exposure.
Huang YC; Lin TY; Chiu CH
Pediatr Infect Dis J; 1995 Feb; 14(2):152-4. PubMed ID: 7746701
[No Abstract] [Full Text] [Related]
17. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
Plans-Rubió P
Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
Nyerges G; Mészner Z; Simon M
Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
